According to these studies, we conclude that different molecular mechanisms may cause the skewing of the CD4+/CD8+ T-cell ratio and the reason is not clear for the changes of CD4+ T-cells in GC patients, which needs further clinical investigations. The gene discussed is CD4; the disease is gastric cancer.